HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Song Selected Research

Tumor Biomarkers (Tumor Markers)

12/2021Simultaneous in situ detection of protein expression of multiple tumor markers of circulating tumor cells and heteroploid of chromosome 8 in primary lung cancer.
8/2021Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer.
2/2019Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Song Research Topics

Disease

121Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 04/2008
95Neoplasms (Cancer)
05/2024 - 07/2004
58Lung Neoplasms (Lung Cancer)
11/2023 - 04/2008
32Adenocarcinoma of Lung
11/2023 - 10/2009
27Neoplasm Metastasis (Metastasis)
01/2024 - 09/2009
22Inflammation (Inflammations)
12/2023 - 09/2003
16Acute Lung Injury
04/2024 - 04/2003
13Pneumonia (Pneumonitis)
01/2024 - 01/2014
13Lung Injury
04/2022 - 10/2009
12Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024 - 09/2009
12Disease Progression
02/2024 - 09/2013
11Carcinogenesis
07/2022 - 09/2009
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2013
9Malignant Pleural Effusion
09/2019 - 01/2012
8Endometriosis
10/2023 - 04/2013
7Pleural Effusion (Pleural Effusions)
04/2020 - 01/2012
7Exanthema (Rash)
01/2020 - 01/2013
7Asthma (Bronchial Asthma)
01/2019 - 03/2007
7Hemorrhagic Shock
01/2009 - 04/2003
6Brain Neoplasms (Brain Tumor)
04/2023 - 01/2017
6Adenocarcinoma
12/2021 - 09/2009
5Sepsis (Septicemia)
04/2022 - 08/2002
5Carcinoma (Carcinomatosis)
12/2021 - 09/2009
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 01/2009
5Lymphatic Metastasis
01/2017 - 01/2009
5Lung Diseases (Lung Disease)
06/2015 - 04/2008
4Infections
02/2024 - 03/2011
4Wounds and Injuries (Trauma)
01/2024 - 01/2013
4Necrosis
01/2022 - 12/2006
4Food Hypersensitivity (Food Allergy)
02/2021 - 01/2017
4Hemorrhage
02/2021 - 04/2003
4Insulin Resistance
04/2016 - 11/2011
3Bites and Stings (Sting)
04/2024 - 01/2021
3COVID-19
02/2024 - 01/2021
3Ventilator-Induced Lung Injury
10/2023 - 10/2018
3Chronic Obstructive Pulmonary Disease (COPD)
06/2023 - 03/2007
3Fibrosis (Cirrhosis)
01/2023 - 11/2019
3Atrophy
01/2022 - 01/2014
3Breast Neoplasms (Breast Cancer)
06/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
02/2022 - 07/2004
33Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2009
28ErbB Receptors (EGF Receptor)IBA
01/2024 - 03/2011
21Immune Checkpoint InhibitorsIBA
01/2024 - 12/2017
16Tyrosine Kinase InhibitorsIBA
09/2023 - 03/2011
14Long Noncoding RNAIBA
03/2023 - 04/2015
11PlatinumIBA
03/2024 - 03/2011
11RNA (Ribonucleic Acid)IBA
10/2022 - 04/2004
10MicroRNAs (MicroRNA)IBA
10/2023 - 09/2012
9CytokinesIBA
01/2023 - 07/2012
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 09/2009
9Small Interfering RNA (siRNA)IBA
01/2020 - 11/2013
9Messenger RNA (mRNA)IBA
01/2019 - 09/2005
8LipopolysaccharidesIBA
04/2024 - 09/2005
8icotinibIBA
02/2020 - 09/2013
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 04/2003
7CrizotinibIBA
02/2024 - 01/2015
6Anaplastic Lymphoma KinaseIBA
02/2024 - 01/2015
6LigandsIBA
01/2024 - 04/2015
5InterferonsIBA
04/2024 - 04/2020
5osimertinibIBA
09/2023 - 01/2019
5Docetaxel (Taxotere)FDA Link
12/2022 - 07/2014
5Interleukin-6 (Interleukin 6)IBA
11/2022 - 07/2012
5Gefitinib (Iressa)FDA Link
12/2020 - 03/2011
5Cadherins (E-Cadherin)IBA
10/2019 - 11/2013
5CateninsIBA
02/2017 - 04/2015
4Indicators and Reagents (Reagents)IBA
11/2022 - 06/2012
4Phosphotransferases (Kinase)IBA
11/2022 - 05/2014
4Topotecan (Hycamtin)FDA LinkGeneric
04/2022 - 10/2018
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2018
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 11/2012
4VimentinIBA
12/2021 - 11/2013
4Carcinoembryonic AntigenIBA
08/2021 - 04/2014
4AlbuminsIBA
03/2021 - 09/2014
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 03/2011
4Carboplatin (JM8)FDA LinkGeneric
01/2021 - 09/2014
4Farnesyltranstransferase (Farnesyltransferase)IBA
01/2021 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2008
4Circulating Tumor DNAIBA
01/2021 - 04/2020
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 09/2005
4Mitochondrial DNA (mtDNA)IBA
11/2019 - 01/2013
4HMGB1 Protein (HMG1)IBA
10/2017 - 09/2009
4enhanced green fluorescent proteinIBA
09/2012 - 07/2010
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2012 - 08/2002
3Etoposide (VP 16)FDA LinkGeneric
03/2024 - 01/2018
3ensartinibIBA
02/2024 - 01/2020
3Programmed Cell Death 1 ReceptorIBA
01/2023 - 01/2022
3Estrogens (Estrogen)FDA Link
01/2023 - 04/2013
39 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
04/2022 - 01/2019
3GemcitabineFDA Link
01/2022 - 09/2014
3Tumor Biomarkers (Tumor Markers)IBA
12/2021 - 02/2019
3Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 09/2011

Therapy/Procedure

43Therapeutics
01/2024 - 12/2008
42Drug Therapy (Chemotherapy)
06/2023 - 09/2009
24Immunotherapy
05/2024 - 03/2014
7Radiotherapy
06/2023 - 09/2009
6Artificial Respiration (Mechanical Ventilation)
10/2023 - 05/2014
6Punctures
04/2022 - 09/2005
3Neoadjuvant Therapy
11/2023 - 01/2022
3Lymph Node Excision (Lymph Node Dissection)
11/2023 - 02/2015
3Lasers (Laser)
01/2022 - 04/2008